Navigation Links
Sunrise Biotech Holding Limited Application For Admission to PLUS
Date:11/14/2007

BEIJING, Nov. 14 /Xinhua-PRNewswire/ -- The directors of Sunrise Biotech Holding Limited ("Sunrise" or the "Company"), a leading producer of organic mulberry-based products in China, are pleased to announce the Company has applied for the admission of its entire ordinary share capital for trading on the PLUS Market.

LISTING DETAILS

SECTOR CLASSIFICATION Biology Technology

PRINCIPLE ACTIVITIES The development and production of

mulberry tree-based organic

products -- namely: mulberry tea,

mulberry leaf powder and tablets

for use in food additives and

herbal remedies, and mulberry

leaf powder and granules for use

as animal fodder

OVERVIEW

Sunrise Biotech Holding Limited is a recently formed holding company incorporated in Jersey that owns 100% of the total share capital of Beijing Sunrise, which, in turn, owns 100% of the total share capital of Hebei Sunrise (together "the Group"). Founded January 2005, Beijing Sunrise develops and produces organic mulberry-based products from three locations in the Yongledian Region of Beijing. Hebei Sunrise, founded May 2005, operates from one location in the Hebei region of China. Currently, the Company's product range is focused on the production of mulberry tea, mulberry leaf powder and tablets for use in food additives and herbal remedies, and mulberry leaf powder and granules for use as animal fodder.

The Group's production base currently consists of over 3,100 acres of leased land, which produces an annual mulberry leaf capacity of 24,000 tons. In 2006, the Company generated net profits of GBP1,432,72.

ANTICIPATED ADMISSION

Yonghu Li, chairman of Sunrise Holding Ltd., commented: "The Admission on the PLUS market represents a significant development for the Company which has the potential to improve its corporate governance and raise funds for its future development."

Fortunes Capital, one of the renowned financial advisory firms, has led in the listing process. Steve Wayne, president of Fortunes Capital (China), said: "Sunrise Biotech is a unique company with great potential for growth, which is one of few companies to advocate mulberry-based food and healthcare solutions. Sunrise is establishing its leading stand in this market segmentation of China biotech Industry."

Trading in the Company's shares on PLUS is expected before the end of December 2007. An announcement will be loaded onto the PLUS official website in the near future.


'/>"/>
SOURCE Sunrise Biotech Holding Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 Ginkgo Bioworks, the organism company, ... in the synthesis and assembly of DNA. The ... pathway-length synthetic DNA into Ginkgo,s automated organism engineering ... construction of new organism designs for application across ... was founded to significantly increase the world,s capacity ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... formation of its Medical/Clinical Advisory Board.  This new ... who enhance the range and depth of expertise ... its novel prenatal diagnostic tests.  These experts are ... guidance for the company,s product development and commercialization ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , ... PIP) and Altimmune, Inc., a privately-held immunotherapeutics company ... a definitive agreement for the merger of PharmAthene ... investors include Novartis Venture Fund, HealthCap, Truffle Capital ... a fully-integrated and diversified immunotherapeutics company with four ...
(Date:1/19/2017)... NY (PRWEB) , ... January 19, 2017 , ... FireflySci ... an exponential rate. The tremendous growth is accounted to two main factors. ... table and the expanding network of vendors supplying FireflySci products all around the world. ...
Breaking Biology Technology:
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
Breaking Biology News(10 mins):